Skip to main content
SpringerLink
Log in

Postchemotherapy Retroperitoneal Lymph Node Dissection

  • Chapter
  • First Online:
Cancer of the Testis

  • 802 Accesses

Abstract

Postchemotherapy surgery for the management of advanced germ cell tumors (GCT) has evolved significantly over the past 25 years (Sheinfeld et al. 1997; Bajorin et al. 1992; Sheinfeld 2002). Prior to the utilization of platinum-based regimens, surgical debulking was followed by ineffective chemotherapy resulting in high relapse rates and poor overall survival (Merrin et al. 1977; Donohue et al. 1980). Improvements in radiographic staging, a better understanding of the role of serum tumor markers, and the introduction of cisplatinbased chemotherapy have all contributed to postchemotherapy surgery assuming a more central role in the management of patients with advanced GCT (Bosl et al. 2005; Donohue et al. 1982; Einhorn 1981; Donohue and Rowland 1984). This multimodal approach has resulted in survival rates approaching 80% in patients with advanced GCT (Sheinfeld et al. 1997; Einhorn 1981; Bosl et al. 1986).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abdel-Aziz KF, Anderson JK, Svatek R, Margulis V, Sagalowsky AI, Cadeddu JA (2006) Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors. J Endourol 20:627

    Article  PubMed  Google Scholar 

  • Ahmed T, Bosl GJ, Hajdu SI (1985) Teratoma with malignant transformation in germ cell tumors in men. Cancer 56:860

    Article  PubMed  CAS  Google Scholar 

  • Albers P, Weissbach L, Krege S, Kliesch S, Hartmann M, Heidenreich A, Walz P, Kuczyk M, Fimmers R (2004) Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group. J Urol 171:1835

    Article  PubMed  Google Scholar 

  • Bajorin DF, Herr H, Motzer RJ, Bosl GJ (1992) Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors. Semin Oncol 19:148

    PubMed  CAS  Google Scholar 

  • Baniel J, Sella A (1999) Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post- chemotherapy. Semin Surg Oncol 17:263

    Article  PubMed  CAS  Google Scholar 

  • Baniel J, Foster RS, Einhorn LH, Donohue JP (1995) Late relapse of clinical stage I testicular cancer. J Urol 154:1370

    Article  PubMed  CAS  Google Scholar 

  • Becherer A, De Santis M, Karanikas G, Szabo M, Bokemeyer C, Dohmen BM, Pont J, Dudczak R, Dittrich C, Kletter K (2005) FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals. Eur J Radiol 54:284

    Article  PubMed  Google Scholar 

  • Beck SD, Foster RS, Bihrle R, Koch MO, Wahle GR, Donohue JP (2001) Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection. J Urol 165:1517

    Article  PubMed  CAS  Google Scholar 

  • Beck SD, Foster RS, Bihrle R, Ulbright T, Koch MO, Wahle GR, Einhorn LH, Donohue JP (2002) Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer. J Urol 168:1402

    Article  PubMed  Google Scholar 

  • Borge N, Fossa SD, Ous S, Stenwig AE, Lien HH (1988) Late recurrence of testicular cancer. J Clin Oncol 6:1248

    PubMed  CAS  Google Scholar 

  • Bosl GJ, Gluckman R, Geller NL, Golbey RB, Whitmore WF Jr, Herr H, Sogani P, Morse M, Martini N, Bains M et al (1986) VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. J Clin Oncol 4:1493

    PubMed  CAS  Google Scholar 

  • Bosl GJ, Geller NL, Bajorin D, Leitner SP, Yagoda A, Golbey RB, Scher H, Vogelzang NJ, Auman J, Carey R et al (1988) A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 6:1231

    PubMed  CAS  Google Scholar 

  • Bosl G, Bajorin D, Sheinfeld J (2005) Cancer of the testis. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 7th edn. Lippincott, Williams, & Wilkins, Philadelphia, pp. 1269–1290

    Google Scholar 

  • Carter GE, Lieskovsky G, Skinner DG, Daniels JR (1987) Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors. J Urol 138:1397

    PubMed  CAS  Google Scholar 

  • Carver BS, Bianco FJ Jr, Shayegan B, Vickers A, Motzer RJ, Bosl GJ, Sheinfeld J (2006a) Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection. J Urol 176:100

    Article  PubMed  Google Scholar 

  • Carver BS, Shayegan B, Motzer RJ, Stasi J, Bajorin D, Bosl GJ, Sheinfeld J (2006b) The incidence and implications of disease outside a modified template in men undergoing post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic non-seminomatous germ cell tumors (NSGCT). J Urol 175:192

    Google Scholar 

  • Chang SS, Mohseni HF, Leon A, Sheinfeld J (2002) Paracolic recurrence: the importance of wide excision of the spermatic cord at retroperitoneal lymph node dissection. J Urol 167:94

    Article  PubMed  Google Scholar 

  • Coogan CL, Hejase MJ, Wahle GR, Foster RS, Rowland RG, Bihrle R, Donohue JP (1996) Nerve sparing post- chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer. J Urol 156:1656

    Article  PubMed  CAS  Google Scholar 

  • Cremerius U, Wildberger JE, Borchers H, Zimny M, Jakse G, Gunther RW, Buell U (1999) Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?–results of a study in 50 patients. Urology 54:900

    Article  PubMed  CAS  Google Scholar 

  • Debono DJ, Heilman DK, Einhorn LH, Donohue JP (1997) Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol 15:1455

    PubMed  CAS  Google Scholar 

  • Dieckmann KP, Albers P, Classen J, De Wit M, Pichlmeier U, Rick O, Mullerleile U, Kuczyk M (2005) Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases. J Urol 173:824

    Article  PubMed  Google Scholar 

  • Donadio AC, Motzer RJ, Bajorin DF, Kantoff PW, Sheinfeld J, Houldsworth J, Chaganti RS, Bosl GJ (2003) Chemotherapy for teratoma with malignant transformation. J Clin Oncol 21:4285

    Article  PubMed  CAS  Google Scholar 

  • Donat SM, Levy DA (1998) Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary? J Urol 160:1347

    Article  PubMed  CAS  Google Scholar 

  • Donohue JP (1977) Retroperitoneal lymphadenectomy: the anterior approach including bilateral suprarenal-hilar dissection. Urol Clin North Am 4:509

    PubMed  CAS  Google Scholar 

  • Donohue JP, Rowland RG (1984) The role of surgery in advanced testicular cancer. Cancer 54:2716

    Article  PubMed  CAS  Google Scholar 

  • Donohue JP, Einhorn LH, Williams SD (1980) Cytoreductive surgery for metastatic testis cancer: considerations of timing and extent. J Urol 123:876

    PubMed  CAS  Google Scholar 

  • Donohue JP, Roth LM, Zachary JM, Rowland RG, Einhorn LH, Williams SG (1982) Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy. J Urol 127:1111

    PubMed  CAS  Google Scholar 

  • Donohue JP, Rowland RG, Kopecky K, Steidle CP, Geier G, Ney KG, Einhorn L, Williams S, Loehrer P (1987) Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 137:1176

    PubMed  CAS  Google Scholar 

  • Donohue JP, Leviovitch I, Foster RS, Baniel J, Tognoni P (1998) Integration of surgery and systemic therapy: results and principles of integration. Semin Urol Oncol 16:65

    PubMed  CAS  Google Scholar 

  • Eastham JA, Wilson TG, Russell C, Ahlering TE, Skinner DG (1994) Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 43:74

    Article  PubMed  CAS  Google Scholar 

  • Eggener SE, Carver BS, Loeb S, Kondagunta GV, Bosl GJ, Sheinfeld J (2007) Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors. Cancer 109:528

    Article  PubMed  Google Scholar 

  • Einhorn LH (1981) Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 41:3275

    PubMed  CAS  Google Scholar 

  • Einhorn LH, Williams SD, Troner M, Birch R, Greco FA (1981a) The role of maintenance therapy in disseminated testicular cancer. N Engl J Med 305:727

    Article  PubMed  CAS  Google Scholar 

  • Einhorn LH, Williams SD, Mandelbaum I, Donohue JP (1981b) Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 48:904

    Article  PubMed  CAS  Google Scholar 

  • Einhorn LH, Williams SD, Loehrer PJ, Birch R, Drasga R, Omura G, Greco FA (1989) Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol 7:387

    PubMed  CAS  Google Scholar 

  • Fizazi K, Tjulandin S, Salvioni R, Germa-Lluch JR, Bouzy J, Ragan D, Bokemeyer C, Gerl A, Flechon A, de Bono JS, Stenning S, Horwich A, Pont J, Albers P, De Giorgi U, Bower M, Bulanov A, Pizzocaro G, Aparicio J, Nichols CR, Theodore C, Hartmann JT, Schmoll HJ, Kaye SB, Culine S, Droz JP, Mahe C (2001) Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy–results from an international study group. J Clin Oncol 19:2647

    PubMed  CAS  Google Scholar 

  • Fossa SD, Ous S, Lien HH, Stenwig AE (1989a) Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer. J Urol 141:557

    PubMed  CAS  Google Scholar 

  • Fossa SD, Aass N, Ous S, Hoie J, Stenwig AE, Lien HH, Paus E, Kaalhus O (1989b) Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. J Urol 142:1239

    PubMed  CAS  Google Scholar 

  • Fossa SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE (1992) Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol 10:569

    PubMed  CAS  Google Scholar 

  • Fox EP, Weathers TD, Williams SD, Loehrer PJ, Ulbright TM, Donohue JP, Einhorn LH (1993) Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol 11:1294

    PubMed  CAS  Google Scholar 

  • Freiha FS, Shortliffe LD, Rouse RV, Mark JB, Hannigan JF Jr, Aston D, Spaulding JT, Williams RD, Torti FM (1984) The extent of surgery after chemotherapy for advanced germ cell tumors. J Urol 132:915

    PubMed  CAS  Google Scholar 

  • Gelderman WA, Schraffordt Koops H, Sleijfer DT, Oosterhuis JW, Van der Heide JN, Mulder NH, Marrink J, De Bruyn HW, Oldhoff J (1988) Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy. J Surg Oncol 38:227

    Article  PubMed  CAS  Google Scholar 

  • Geller NL, Bosl GJ, Chan EY (1989) Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors. Cancer 63:440

    Article  PubMed  CAS  Google Scholar 

  • George DW, Foster RS, Hromas RA, Robertson KA, Vance GH, Ulbright TM, Gobbett TA, Heiber DJ, Heerema NA, Ramsey HC, Thurston VC, Jung SH, Shen J, Finch DE, Kelley MR, Einhorn LH (2003) Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol 21:113

    Article  PubMed  Google Scholar 

  • Gerl A, Clemm C, Schmeller N, Hentrich M, Lamerz R, Wilmanns W (1997) Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 8:41

    Article  PubMed  CAS  Google Scholar 

  • Hendry WF, A’Hern RP, Hetherington JW, Peckham MJ, Dearnaley DP, Horwich A (1993) Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br J Urol 71:208

    Article  PubMed  CAS  Google Scholar 

  • Hendry WF, Norman AR, Dearnaley DP, Fisher C, Nicholls J, Huddart RA, Horwich A (2002) Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer 94:1668

    Article  PubMed  Google Scholar 

  • Husband JE, Hawkes DJ, Peckham MJ (1982) CT estimations of mean attenuation values and volume in testicular tumors: a comparison with surgical and histologic findings. Radiology 144:553

    PubMed  CAS  Google Scholar 

  • Kelly R, Skinner D, Yellin AE, Weaver FA (1995) En bloc aortic resection for bulky metastatic germ cell tumors. J Urol 153:1849

    Article  PubMed  CAS  Google Scholar 

  • Leibovitch I, Rowland RG, Goldwasser B, Donohue JP (1995) Incidental appendectomy during urological surgery. J Urol 154:1110

    Article  PubMed  CAS  Google Scholar 

  • Leibovitch I, Nash PA, Little JS Jr, Foster RS, Donohue JP (1996) Spinal cord ischemia after post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell cancer. J Urol 155:947

    Article  PubMed  CAS  Google Scholar 

  • Levi JA, Thomson D, Sandeman T, Tattersall M, Raghavan D, Byrne M, Gill G, Harvey V, Burns I, Snyder R (1988) A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up. J Clin Oncol 6:1154

    PubMed  CAS  Google Scholar 

  • Levitt MD, Reynolds PM, Sheiner HJ, Byrne MJ (1985) Non-seminomatous germ cell testicular tumours: residual masses after chemotherapy. Br J Surg 72:19

    Article  PubMed  CAS  Google Scholar 

  • Loehrer PJ Sr, Hui S, Clark S, Seal M, Einhorn LH, Williams SD, Ulbright T, Mandelbaum I, Rowland R, Donohue JP (1986) Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation. J Urol 135:1183

    PubMed  Google Scholar 

  • Logothetis CJ, Samuels ML (1984) Surgery in the management of stage III germinal cell tumors. Observations on the M.D. Anderson Hospital experience, 1971-1979. Cancer Treat Rev 11:27

    Google Scholar 

  • Logothetis CJ, Samuels ML, Trindade A, Johnson DE (1982) The growing teratoma syndrome. Cancer 50:1629

    Article  PubMed  CAS  Google Scholar 

  • McKiernan JM, Motzer RJ, Bajorin DF, Bacik J, Bosl GJ, Sheinfeld J (2003) Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome. Urology 62:732

    Article  PubMed  Google Scholar 

  • Mead GM, Stenning SP, Parkinson MC, Horwich A, Fossa SD, Wilkinson PM, Kaye SB, Newlands ES, Cook PA (1992) The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol 10:85

    PubMed  CAS  Google Scholar 

  • Melchior D, Muller SC, Albers P (2003) Extensive surgery in metastatic testicular cancer. Aktuelle Urol 34:214

    Article  PubMed  CAS  Google Scholar 

  • Merrin C, Takita H, Beckley S, Kassis J (1977) Treatment of recurrent and widespread testicular tumor by radical reductive surgery and multiple sequential chemotherapy. J Urol 117:291

    PubMed  CAS  Google Scholar 

  • Morgentaler A, Garnick MB, Richie JP (1988) Metastatic testicular teratoma invading the inferior vena cava. J Urol 140:149

    PubMed  CAS  Google Scholar 

  • Mosharafa AA, Foster RS, Koch MO, Bihrle R, Donohue JP (2004) Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 171:1839

    Article  PubMed  Google Scholar 

  • Motzer RJ, Bajorin DF, Vlamis V, Weisen S, Bosl GJ (1992) Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience. Semin Oncol 19:8

    PubMed  CAS  Google Scholar 

  • Motzer RJ, Amsterdam A, Prieto V, Sheinfeld J, Murty VV, Mazumdar M, Bosl GJ, Chaganti RS, Reuter VE (1998) Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol 159:133

    Article  PubMed  CAS  Google Scholar 

  • Murphy BR, Breeden ES, Donohue JP, Messemer J, Walsh W, Roth BJ, Einhorn LH (1993) Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 11:324

    PubMed  CAS  Google Scholar 

  • Nash PA, Leibovitch I, Foster RS, Bihrle R, Rowland RG, Donohue JP (1998) En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes. J Urol 159:707

    Article  PubMed  CAS  Google Scholar 

  • Neyer M, Peschel R, Akkad T, Springer-Stohr B, Berger A, Bartsch G, Steiner H (2007) Long-term results of laparoscopic retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testicular cancer. J Endourol 21:180

    Article  PubMed  Google Scholar 

  • Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD (2003) Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 21:3310

    Article  PubMed  Google Scholar 

  • Ozols RF, Ihde DC, Linehan WM, Jacob J, Ostchega Y, Young RC (1988) A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors. J Clin Oncol 6:1031

    PubMed  CAS  Google Scholar 

  • Palese MA, Su LM, Kavoussi LR (2002) Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 60:130

    Article  PubMed  Google Scholar 

  • Peckham MJ (1985) Surveillance following orchiectomy for clinical stage I testicular germ-cell malignancy. Prog Clin Biol Res 203:523

    PubMed  CAS  Google Scholar 

  • Permpongkosol S, Lima GC, Warlick CA, Allaf ME, Varkarakis IM, Bagga HS, Kohanim S, Kavoussi LR (2007) Postchemotherapy laparoscopic retroperitoneal lymph node dissection: evaluation of complications. Urology 69:361

    Article  PubMed  Google Scholar 

  • Pettus JA, Carver BS, Stasi J, Sheinfeld J (2007) Preservation of ejaculation in patients in undergoing nerve-sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer. J Urol 177:278

    Article  Google Scholar 

  • Pfister D, Ohlmann CH, Thuer D, Sahi D, Heidenreich A (2007) Post-chemotherapy retroperitoneal resection of residual masses in germ cell cancer with modified template resection. J Urol 177:330

    Google Scholar 

  • Rassweiler JJ, Henkel TO, Stock C, Seemann O, Frede T, Alken P (1996) Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy. Lymphology 29:36

    PubMed  CAS  Google Scholar 

  • Richie JP (1984) The surgical management of advanced abdominal disease. Semin Urol 2:238

    PubMed  CAS  Google Scholar 

  • Richie JP, Garnick MB, Finberg H (1982) Computerized tomography: how accurate for abdominal staging of testis tumors? J Urol 127:715

    PubMed  CAS  Google Scholar 

  • Rick O, Bokemeyer C, Weinknecht S, Schirren J, Pottek T, Hartmann JT, Braun T, Rachud B, Weissbach L, Hartmann M, Siegert W, Beyer J (2004) Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. J Clin Oncol 22:3713

    Article  PubMed  CAS  Google Scholar 

  • Sexton WJ, Wood CG, Kim R, Pisters LL (2003) Repeat retroperitoneal lymph node dissection for metastatic testis cancer. J Urol 169:1353

    Article  PubMed  Google Scholar 

  • Sheinfeld J (2002) The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies. Semin Urol Oncol 20:262

    Article  PubMed  Google Scholar 

  • Sheinfeld J, Sogani P. (2007) Re-operative retroperitoneal surgery in testicular cancer. Urol Clin North Am 34(2):227-233

    Google Scholar 

  • Sheinfeld J, Bajorin D, Solomon M (1997) Management of postchemotherapy residual masses in advanced germ cell tumors. AUA Update Series 17:18

    Google Scholar 

  • Sheinfeld J, McKernian J, Bosl GJ (2002) Surgery of testicular tumors. In: Walsh PC, Retick AB, Vaughan ED Jr, Wein AJ (eds) Campbell’s urology, 8th edn. W.B. Saunders, Philadelphia, pp 2920–2944

    Google Scholar 

  • Spermon JR, De Geus-Oei LF, Kiemeney LA, Witjes JA, Oyen WJ (2002) The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours. BJU Int 89:549

    Article  PubMed  CAS  Google Scholar 

  • Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fossa SD, Horwich A, Jones WG, Newlands ES, Oliver RT, Stenwig AE, Wilkinson PM (1998) Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party. Cancer 83:1409

    Article  PubMed  CAS  Google Scholar 

  • Stephenson AJ, Tal R, Sheinfeld J (2006) Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer. J Urol 176:1996

    Article  PubMed  Google Scholar 

  • Steyerberg EW, Keizer HJ, Fossa SD, Sleijfer DT, Toner GC, Schraffordt Koops H, Mulders PF, Messemer JE, Ney K, Donohue JP et al (1995) Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 13:1177

    PubMed  CAS  Google Scholar 

  • Steyerberg EW, Gerl A, Fossa SD, Sleijfer DT, de Wit R, Kirkels WJ, Schmeller N, Clemm C, Habbema JD, Keizer HJ (1998) Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer. J Clin Oncol 16:269

    PubMed  CAS  Google Scholar 

  • Steyerberg EW, Vergouwe Y, Keizer HJ, Habbema JD (2001) Residual mass histology in testicular cancer: development and validation of a clinical prediction rule. Stat Med 20:3847

    Article  PubMed  CAS  Google Scholar 

  • Stomper PC, Jochelson MS, Garnick MB, Richie JP (1985) Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology. AJR Am J Roentgenol 145:743

    PubMed  CAS  Google Scholar 

  • Tait D, Peckham MJ, Hendry WF, Goldstraw P (1984) Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 50:601

    Article  PubMed  CAS  Google Scholar 

  • Toner GC, Panicek DM, Heelan RT, Geller NL, Lin SY, Bajorin D, Motzer RJ, Scher HI, Herr HW, Morse MJ et al (1990) Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 8:1683

    PubMed  CAS  Google Scholar 

  • Ulbright TM, Loehrer PJ, Roth LM, Einhorn LH, Williams SD, Clark SA (1984) The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer 54:1824

    Google Scholar 

  • Vergouwe Y, Steyerberg EW, Foster RS, Sleijfer DT, Fossa SD, Gerl A, de Wit R, Roberts JT, Habbema JD (2007) Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients. Eur Urol 51:424

    Article  PubMed  Google Scholar 

  • Wahle GR, Foster RS, Bihrle R, Rowland RG, Bennett RM, Donohue JP (1994) Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma. J Urol 152:428

    PubMed  CAS  Google Scholar 

  • Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316:1435

    Article  PubMed  CAS  Google Scholar 

  • Wittenhuhn R, De Geeter P, Albers P (2007) Retroperitoneal residual tumor resection for testicular cancer – template instead of full bilateral resection. J Urol 177:331

    Article  Google Scholar 

  • Wood DP Jr, Herr HW, Heller G, Vlamis V, Sogani PC, Motzer RJ, Fair WR, Bosl GJ (1992a) Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol 148:1812

    PubMed  Google Scholar 

  • Wood DP Jr, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ (1992b) Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer 70:2354

    Article  PubMed  Google Scholar 

  • Wozniak AJ, Samson MK, Shah NT, Crawford ED, Ford CD, Altman SJ, Stephens RL, Natale RB, Bouroncle BA, Blumenstein BA et al (1991) A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study. J Clin Oncol 9:70

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA

    Joel Sheinfeld

Authors
  1. Jay D. Raman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Albers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joel Sheinfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Academic Medical Center, Dept. Urology, University of Amsterdam, Meibergdreef 9, Amsterdam, 1050 AZ, Netherlands

    M. Pilar Laguna

  2. Urologische Klinik, Klinikum Kassel GmbH, Mönchebergstr. 41-43, Kassel, 34125, Germany

    Peter Albers

  3. Zentrum für Innere Medizin, Klinik für Onkologie, Hämatologie und, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany

    Carsten Bokemeyer

  4. Division of Urology, Brigham & Women’s Hospital, Francis St. 45, Boston, 02115, Massachusetts, USA

    Jerome P. Richie

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Raman, J.D., Albers, P., Sheinfeld, J. (2011). Postchemotherapy Retroperitoneal Lymph Node Dissection. In: Laguna, M., Albers, P., Bokemeyer, C., Richie, J. (eds) Cancer of the Testis. Springer, London. https://doi.org/10.1007/978-1-84800-370-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-370-5_15

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-369-9

  • Online ISBN: 978-1-84800-370-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation